Related Experiment Video
Updated: Oct 1, 2025
07:28
Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
40.9K
Inhaled corticosteroids and COVID-19 outcomes in asthma: the Israeli experience
Yochai Adir1,2, Einat Fireman Klein1,2, Walid Saliba2,3
1Pulmonary Division, Lady Davis Carmel Medical Center, Faculty of Medicine Technion Institute of Technology, Haifa, Israel.
ERJ Open Research
|March 9, 2022
Summary
Inhaled corticosteroid (ICS) use is safe for asthma patients during the COVID-19 pandemic. Individuals with asthma should continue their prescribed ICS treatments without interruption.
Area of Science:
- Pulmonology
- Infectious Disease Epidemiology
Background:
- The COVID-19 pandemic raised concerns about the safety of inhaled corticosteroid (ICS) medications for asthma patients.
- Understanding the impact of continued ICS use on COVID-19 outcomes is crucial for patient management.
Purpose of the Study:
- To assess the safety of continued inhaled corticosteroid (ICS) use in individuals with asthma during the COVID-19 pandemic.
- To provide guidance on asthma medication adherence during public health crises.
Main Methods:
- Review of current evidence and clinical guidelines regarding ICS use in asthma.
- Analysis of potential risks and benefits of ICS therapy in the context of SARS-CoV-2 infection.
Main Results:
- Inhaled corticosteroids (ICS) are considered safe for patients with asthma.
- There is no evidence to suggest that continuing prescribed ICS medication increases the risk of severe COVID-19 outcomes.
Conclusions:
- Individuals with asthma should continue their prescribed inhaled corticosteroid (ICS) treatment as usual.
- Maintaining asthma control through regular ICS use is paramount during the COVID-19 pandemic.
Related Concept Videos
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
428
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
428
01:26COPD: Management Using Bronchodilators and Corticosteroids
443
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
443
01:20Asthma: Pathogenesis and Management
786
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
786
01:23Inhaled Medications
443
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
443
01:30Asthma-IV: Diagnostic and Management
2.7K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.7K
01:17Drugs Used in Lower Respiratory Disorders: Overview
675
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
675